Garg A, van der Zee HH, Geng Z, Mulder GD. Impact of Baseline Smoking Status and Body Mass Index in Patients with Hidradenitis Suppurativa Treated with Adalimumab or Placebo in Phase 2 or 3 Studies. J of Skin [Internet]. 2017 Oct. 27 [cited 2024 Jul. 22];1(3.1):s130. Available from: https://jofskin.org/33014/index.php/skin/article/view/74